This new publication proposes an analyzis of pharma companies’ reputation and practical recommendations to improve the opinion of their core stakeholders.
News
The quality of Medical Brand Plans is often sub-optimal due to aweak building process, a lack of...
Brand plans are often of limited value due to a weak development process, insufficient market insights, and...
In this new position paper, we propose a proven and straightforward methodology to help the management of...